Advertisement

Topics

Evotec takes on Sanofi’s infectious disease unit as it aims to develop new anti-infectives

12:40 EDT 18 Jun 2018 | Outsourcing-Pharma

Evotec is integrating Sanofiâs infectious disease unit into its organization and will collaborate to launch new "open innovation" initiatives aimed at accelerating infectious disease research.

Original Article: Evotec takes on Sanofi’s infectious disease unit as it aims to develop new anti-infectives

NEXT ARTICLE

More From BioPortfolio on "Evotec takes on Sanofi’s infectious disease unit as it aims to develop new anti-infectives"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...